Advertisement
Advertisement

KPRX

KPRX logo

Kiora Pharmaceuticals, Inc. Common Stock

2.58
USD
Sponsored
-0.06
-2.27%
Aug 10, 16:00 UTC -4
Closed
exchange

After-Market

2.57

-0.01
-0.39%

Kiora Pharmaceuticals, Inc. Common Stock Profile

About

Kiora Pharmaceuticals Inc. is a clinical-stage specialty pharmaceutical company. It involved in developing and commercializing products for treating ophthalmic diseases. The company's product pipeline includes KIO-301, KIO-101 and KIO-201. Kiora Pharmaceuticals Inc., formerly known as EyeGate Pharmaceuticals Inc., is based in SALT LAKE CITY.

Info & Links

CEO

Brian M. Strem

Headquarters

169 SAXONY RD., SUITE 212
ENCINITAS, CA 92024, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.kiorapharma.com

Auditor

Haskell & White LLP

Share holders

28

Employees

13

Kiora Pharmaceuticals, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

11.39M

Enterprise Value

4.31M

Enterprise Value/EBITDA(ttm)

-0.34

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.84

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-62.81%

Return on Invested Capital(ttm)

-67.37%

Return on Assets(ttm)

-43.74%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-12.79M

Net Income Available to Common(ttm)

-10.99M

Diluted EPS(ttm)

-2.51

Share Statistics

Beta (5Y Monthly)

-0.38

52-Week Change

9.32%

S&P 500 52-Week Change

21.65%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

4.42M

Dividend Yield

0.00%

Float4

4.41M

% Held by Insiders

0.52%

% Held by Institutions

76.97%

Balance Sheet

Total Cash(mrq)

16.84M

Total Cash Per Share(mrq)

3.81

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

6.68%

Quick Ratio(mrq)

6.68%

Book Value Per Share(mrq)

3.49

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.76

Free Cash Flow(ytd)

-3.17M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement